Type-III interferons and rheumatoid arthritis: Correlation between interferon lambda 1 (interleukin 29) and antimutated citrullinated vimentin antibody levels
Aim: To assess serum type III or lambda (λ) interferons (IFN) levels and its clinical and laboratory associations in rheumatoid arthritis (RA). Methods: A cross-sectional study including 43 patients with RA (86% females; age 45.3 ± 10.3 years) and 43 healthy individuals was performed. Clinical data...
Main Authors: | Diana Castillo-Martínez, Maribel Juarez, Mariana Patlán, Araceli Páez, Felipe Massó, Luis M. Amezcua-Guerra |
---|---|
Format: | Article |
Language: | English |
Published: |
Taylor & Francis Group
2017-02-01
|
Series: | Autoimmunity |
Subjects: | |
Online Access: | http://dx.doi.org/10.1080/08916934.2017.1289181 |
Similar Items
-
Assessment of serum antimutated citrullinated vimentin antibodies in rheumatoid arthritis
by: Refaat M El Tanawy, et al.
Published: (2015-01-01) -
Interferons lambda – therapeutic application
by: N. A. Kikhtenko, et al.
Published: (2020-05-01) -
Differing specificities and isotypes of anti-citrullinated peptide/protein antibodies in palindromic rheumatism and rheumatoid arthritis
by: Sonia Cabrera-Villalba, et al.
Published: (2017-06-01) -
Interferon Lambda Signaling Restrains Experimental Autoimmune Encephalomyelitis
by: Mohammad Asif Sherwani, et al.
Published: (2024-02-01) -
Macrophage Coordination of the Interferon Lambda Immune Response
by: Scott A. Read, et al.
Published: (2019-11-01)